- Karmastock
- uploaded: Feb 2, 2012
- Hits: 380
Description:
Athersys Inc - ATHX - reported positive results from its Phase I clinical trial of MultiStem, its cell therapy product, administered to individuals undergoing allogeneic hematopoietic stem cell transplants for the treatment of leukemia and related conditions.
Tags:
Categories:
0 comments
No comments yet.











